Jci_page_head_homepage_01 Jci_page_head_homepage_02
Geneviève de Saint Basile, Frédéric Geissmann, Elisabeth Flori, Béatrice Uring-Lambert, Claire Soudais, Marina Cavazzana-Calvo, Anne Durandy, Nada Jabado, Alain Fischer, Françoise Le Deist
Published in Volume 114, Issue 10
J Clin Invest. 2004; 114(10):1512–1517 doi:10.1172/JCI22588
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

CD3+ thymocyte counts and their proliferation in the thymi from PIII-2 and PIII-3 compared with the thymus from the control fetus. (A) Number of CD3+ thymocytes per high-power field (HPF; magnification, ×40). Fields were chosen at random from CD3ε antibody–labeled sections of PIII-3, PIII-2, and control thymi. CD3 antibody–labeled cells were counted on photographs of 3 fields per sample. The results are presented as the mean and SD of the 3 measurements. (B) Percentage of Ki67+ thymocytes among the CD3+ thymocytes. Fields were photographed at random from Ki67 antibody–labeled sections of PIII-3, PIII-2, and control thymus (magnification, ×40). Ki67 antibody–labeled cells were then counted in 3 fields per sample. The results were plotted against the values obtained for CD3.